By: ifood.tv

Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme

Jul 12, 2013 No Comments by

The primary objective of this trial is to determine the optimal dose and imaging time
point(s) of I-124-CLR1404 in subjects with newly diagnosed and recurrent glioma to be used
in future trials.

Clinical Trial Conditions: Glioblastoma Multiforme

Treatments in this Clinical Trial : I-124-CLR1404

Clinical Trial Phase: Phase 2

Eligible Clinical Trial Participant Age : Between 18 years to 100 years

Can Healthy Volunteers Participate: No

Clinical Trial Lead Sponsor: Novelos Therapeutics

Detailed Clinical Trial Description: The primary objective of this trial is to determine the optimal dose and imaging time
point(s) of I-124-CLR1404 in subjects with newly diagnosed and recurrent glioma to be used
in future trials.

The clinical trial information was obtained from http://clinicaltrials.gov/ct2/show/NCT01898273

New Clinical Trial

About the author

The author didnt add any Information to his profile yet
No Responses to “Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme”

Leave a Reply

By: ifood.tv